Anti-egfr/anti-c-met Bispecific Antibody Emb-01 Uses, Dosage, Side Effects and more
Anti-egfr/anti-c-met Bispecific Antibody Emb-01 is under investigation in clinical trial NCT03797391 (A Dose Escalation Study of Anti-egfr/anti-c-met Bispecific Antibody Emb-01 in Participants With Advanced/metastatic Solid Tumors).
| Trade Name | Anti-egfr/anti-c-met Bispecific Antibody Emb-01 |
| Generic | EMB-01 |
| EMB-01 Other Names | Anti-egfr/anti-c-met bispecific antibody emb-01, Anti-egfr/c-met bispecific antibody emb-01 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
